Consulting & Innovation
Solutions & Products
Infrastructure & Operations
Solutions & Products

Press Release

08. November 2017

France MVO and C.I.P. task Arvato Systems with implementation and operation of IT platform for the verification of serialised medications

Arvato Systems_Gesundheitswesen_Pill package

IT Solution for protecting patients from counterfeit drugs, in compliance with EU legislation

  • Arvato Systems is responsible for the implementation and operation of the IT platform for medication verification in France
  • France MVO, the governing body within Club Inter Pharmaceutique (C.I.P.) responsible for implementation of the European Directive on serialisation in France, has selected Arvato Systems through a national tender process for implementation of this major project

(Arvato Systems) Gütersloh – Counterfeit medication is on the increase around the world – placing patients, the welfare system, the medical distribution sector and the pharmaceutical industry at risk. Directive 2011/62/EU is the start of the EU initiative against counterfeit medications. From 9 February 2019 prescription drugs may only be dispensed in European Union member states if each package has a unique identifier.

The new Medication Verification IT platform to be used by Club Inter Pharmaceutique (C.I.P.) in France will be provided by Arvato Systems. Since January 2013, Arvato Systems has offered an IT solution for protection against counterfeit medicines. This system keeps and manages all the packaging data of medicines that are required by the legislation and were provided by the industry to offer the verification of each package of medication before it is delivered to the patient. This procedure ensures that all the medicines are valid throughout the entire supply and delivery chain.
In order to provide identification, a data matrix code – already available in France – is added to the packaging of the medication. Besides the serial number – one of the keystones of the security concept – the data matrix code contains the product code, information about the batch number and the expiry date. Each package of medication is therefore unique and verification of its authenticity is provided by the individual identification code.
The Club Inter Pharmaceutique, a non-profit organisation, brings together all of the participants in the drug chain: manufacturers, operators, resellers, distributors and professional associations representing dispensary chemists and healthcare establishments. The C.I.P. develops databases and services whose sole aim is to facilitate discussion among the various professions participating in the health sector. Thanks to its independent nature, the C.I.P. performs an essential role in discussions on technical matters with supervisory authorities, notably in the area of traceability.

A special requirement Arvato Systems had to address in the case of C.I.P. was that its Medication Verification platform is not only used in mainland France but in Overseas France as well, in order to provide access for all health professionals and thus guarantee that no counterfeit package may enter the official distribution chain. This is why 24/7 operation and availability of the platform is obligatory.
“With the software solution of Arvato Systems we have the possibility to implement all aspects of the EU anti-counterfeiting directive”, says Patrick Oscar General Manager of C.I.P. “Furthermore we can cope with the high security requirements. Our deadlines are tight, so it was very important to us to choose a reliable partner. We are sure that we made the right choice with Arvato Systems.”

About Arvato Systems

Global IT specialist Arvato Systems supports major companies through digital transformation. More than 3,000 staff in over 25 locations epitomize in-depth technology expertise, industry knowledge and focus on customer requirements. Working as a team, we develop innovative IT solutions, transition our clients into the Cloud, integrate digital processes and take on IT systems operations and support.

In healthcare, Arvato Systems provides its own serialization solutions covering the entire end-to-end process chain. These solutions support both individual producers and national verification systems. Arvato Systems has been approved and certified as an official service provider by the European Medicines Verification Organization (EMVO). We rely on a dedicated team of serialization experts who have already carried out numerous international projects.
As a part of the Bertelsmann-owned Arvato network, we have the unique capability to work across the entire value chain. Our business relationships are personal; we work with our clients as partners, so that together we can achieve long-term success.

Your Contact for press inquiries

Marcus Metzner
Chief Marketing Officer